Install
Stay informed on the latest biopharmaceutical news, trends, and developments in Asia Pacific with BioPharma APAC. BioPharma Asia ( APAC ) provides in-depth analysis, insights, and expert commentary on drug development, regulatory updates, and industry partnerships in the region.
- 60articles · 30d
- 21+ hour agolatest article
- Aug 15, 2026earliest in window
- 97%with images
- 212avg words
- Medical 45
- Health & Wellness 36
- Economy, Business & Finance 23
- Health 20
- Business & Industrial 19
- Science & Technology 17
- Science & Nature 7
- Finance & Business 6
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Data4Life, Monash Health Partner to Accelerate Clinical Trials and Real-World Evidence Generation
1+ week, 6+ day ago (180+ words) 01 September 2026 | Tuesday | News Data4Life and Monash Health have partnered to optimize clinical trial design and execution, complemented by educational workshops and professional training programs, with a shared commitment to improving patient outcomes. The Global Relations Office is a new site launched…...
Thermo Fisher Strengthens China Focus as Biopharma Innovation Gains Global Momentum
1+ week, 6+ day ago (344+ words) 01 September 2026 | Tuesday | News Thermo Fisher Scientific is reinforcing its commitment to China as the country emerges as an increasingly important source of global biopharmaceutical innovation, with Chairman and CEO Marc Casper highlighting opportunities to support Chinese drug developers across discovery,…...
Ascletis Doses First Patient in Global Phase III Programme for Oral GLP-1 Obesity Drug ASC30
1+ week, 6+ day ago (270+ words) 01 September 2026 | Tuesday | News - Expected to enroll approximately 4,600 participants with obesity or overweight across two pivotal trials (AURORA-1 and AURORA-2) in the U.S., Europe, and Canada. - Global Phase III clinical program to investigate efficacy and safety of three maintenance doses (20 mg, 40 mg,…...
WuXi XDC H1 2026 Revenue Jumps 37% to RMB 3.7 Bn on Strong Bioconjugate Demand
2+ week, 5+ day ago (180+ words) 26 August 2026 | Wednesday | Company results WuXi XDC Cayman Inc. (the "WuXi XDC" or the "Group", stock code: 2268.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO) focused on the bioconjugate market, is pleased to announce its interim results for…...
Biocon Partners with Innomar Strategies to Strengthen Canada Supply Chain
3+ week, 9+ hour ago (142+ words) 24 August 2026 | Monday | News Biocon has partnered with Innomar Strategies, a healthcare services and logistics company, to strengthen its pharmaceutical supply chain and distribution network across Canada. Under the collaboration, Innomar Strategies will serve as Biocon’s exclusive third-party logistics (3PL) provider in…...
South Korea’s Rznomics Joins Lilly Gateway Labs in US to Accelerate RNA Gene Therapies
3+ week, 10+ hour ago (159+ words) 24 August 2026 | Monday | News Rznomics Inc.(KOSDAQ: 476830), a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that it is joining Lilly Gateway Labs (LGL) in San Diego, California. Through its entry into Lilly Gateway Labs, Rznomics plans to…...
Henlius, Sandoz Expand Global Biosimilars Alliance with Up to 10 New Antibody Assets
3+ week, 6+ day ago (79+ words) 18 August 2026 | Tuesday | News In April 2025, the two companies entered into an exclusive commercialization partnership for HLX13, Henlius' proposed ipilimumab biosimilar, across 46 countries and regions including Europe and the United States. This new agreement further deepens the existing oncology biosimilars collaboration between…...